Cover Image
市場調查報告書

組織漿菌症:全球臨床實驗檢討

Histoplasmosis Global Clinical Trials Review, H2, 2016

出版商 GlobalData 商品編碼 177221
出版日期 內容資訊 英文 29 Pages
訂單完成後即時交付
價格
Back to Top
組織漿菌症:全球臨床實驗檢討 Histoplasmosis Global Clinical Trials Review, H2, 2016
出版日期: 2016年08月24日 內容資訊: 英文 29 Pages
簡介

組織漿菌症是吸入莢膜組織漿菌的浮遊胞子引發的狀態。主要影響細網內皮層,但幾乎都是無症狀且良性,影響呼吸系統。組織漿菌症症狀常是非常輕且沒有明顯症狀。 但即使病症不重之後也有可能引發組織漿菌症候群(OHS)這種嚴重的眼睛疾病。OHS是失明的主要原因。

本報告提供組織漿菌症的治療藥相關之臨床實驗調查分析,提供您臨床實驗數及受驗人數,各階段及Phase狀況,有潛力的企業,正在開發的治療藥資訊,臨床實驗簡介等相關的系統性資訊。

目錄

簡介

各地區的臨床實驗

  • 各國臨床實驗趨勢
    • 北美的主要國家

G7各國的臨床實驗:感染疾病疾病臨床實驗上組織漿菌症所佔的比例

G7各國的臨床實驗:Phase別

G7各國的臨床實驗:各階段

Phase別臨床實驗

各階段臨床實驗

評估項目別臨床實驗

未完成的臨床實驗

一定期間所採用的實驗對象

贊助商類別臨床實驗

有潛力的贊助商

  • 組織漿菌症的治療藥臨床實驗之主要參與企業

有潛力藥物

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Novartis AG
    • Johnson & Johnson
    • Janssen Pharmaceuticals, Inc.
    • Chemo Espana, S.A.
  • 主要大學·研究機關·醫院臨床實驗概要
    • The National Institute of Allergy and Infectious Diseases
    • National Eye Institute
    • National Center for Research Resources
    • Retina Research Institute of Texas, LLC
    • Retina Associates of Kentucky
    • Barnes Retina Institute

主要的臨床簡介

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3668CTIDB

GlobalData's clinical trial report, "Histoplasmosis Global Clinical Trials Review, H2, 2016" provides an overview of Histoplasmosis clinical trials scenario. This report provides top line data relating to the clinical trials on Histoplasmosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Histoplasmosis to Infectious Disease Clinical Trials
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Histoplasmosis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Histoplasmosis Therapeutics, Global, Clinical Trials by Region, 2016*
  • Histoplasmosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Histoplasmosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Histoplasmosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016*
  • Histoplasmosis Therapeutics Clinical Trials, North America, Top Countries, 2016*
  • Proportion of Histoplasmosis to Infectious Disease Clinical Trials, G7 Countries (%), 2016*
  • Histoplasmosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Histoplasmosis Therapeutics, Global, Clinical Trials by Phase, 2016*
  • Histoplasmosis Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Histoplasmosis Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Histoplasmosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
  • Histoplasmosis Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Histoplasmosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Histoplasmosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*

List of Figures

  • Histoplasmosis Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Histoplasmosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Histoplasmosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Proportion of Histoplasmosis to Infectious Disease Clinical Trials, G7 Countries (%), 2016*
  • Histoplasmosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Histoplasmosis Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Histoplasmosis Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Histoplasmosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
  • Histoplasmosis Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Histoplasmosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Histoplasmosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*
  • GlobalData Methodology
Back to Top